Company Description
SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.
The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products.
It also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a proprietary 3D-printed porous surface and fenestrated design; iFuse TORQ, a line of 3D-printed threaded implants designed for applications in pelvic trauma and sacroliliac fusion; and iFuse Bedrock Granite Implant System that provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion; and iFuse TORQ TNT to treat pelvic trauma and sacroiliac joint dysfunction, as well as iFuse INTRA implants that are marketed as human cells, tissues, and cellular or tissue-based products.
The company markets its products primarily with a direct sales force, as well as through third-party sales agent and resellers.
SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
| Country | United States |
| Founded | 2008 |
| IPO Date | Oct 17, 2018 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 349 |
| CEO | Laura Francis |
Contact Details
Address: 471 El Camino Real, Suite 101 Santa Clara, California 95050 United States | |
| Phone | 408 207 0700 |
| Website | si-bone.com |
Stock Details
| Ticker Symbol | SIBN |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001459839 |
| CUSIP Number | 825704109 |
| ISIN Number | US8257041090 |
| Employer ID | 26-2216351 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Laura A. Francis MBA | Chief Executive Officer and Director |
| Jeffrey W. Dunn | Executive Chairman |
| Anshul Maheshwari | Chief Financial Officer |
| Anthony J. Recupero | President of Commercial Operations |
| Dr. Scott A. Yerby | Senior Vice President of Engineering and Chief Technology Officer |
| Saqib Iqbal | Director of FP&A and Investor Relations |
| Michael A. Pisetsky J.D. | Chief Business and Legal Affairs Officer, Secretary and General Counsel |
| Aimee Einstein | Vice President of People and Culture |
| Dr. Daniel Joseph Cher | Senior Vice President of Clinical and Regulatory Affairs |
| Dr. W. Carlton Reckling | Chief Medical Officer and Vice President of Medical Affairs |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 25, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 25, 2025 | 10-K | Annual Report |
| Feb 24, 2025 | 8-K | Current Report |
| Jan 13, 2025 | 8-K | Current Report |
| Nov 19, 2024 | 144 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 12, 2024 | SCHEDULE 13G | Filing |